QIAGEN extends AI capabilities of its NGS interpretation software QCI Interpret to enable clinical exome completeness - Qiagen (NYSE:QGEN)
Venlo, the Netherlands, and Redwood City, California, Sept. 28, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)) announced today the expansion of its clinical decision support software,